List price doesn't matter in US healthcare FYI.
Re:The Aducanumab Approval
by NoImmatureAdHom on Tuesday June 08, 2021 @07:57PM
(#27442615)
Idk why the downvotes, this person is basically correct. Maybe downvotes because people find it distasteful? Lots of correct things are distasteful.
Here's a discussion of the various ways of thinking about drug pricing in the U.S. (e.g., Average Wholesale Price (AWP). You can search using the acronyms if you're curious: https://www.rjhealth.com/2019/07/31/drug-pricing-101-reimbur...
The fact that pharma has managed to obfuscate true prices is its own indictment of US healthcare.
(edit) made my comment a bit less confrontational in tone
List price is $56,000 per year if you're curious.